Q3 2025 Earnings Call Transcript January 30, 2025 Christopher O’Reilly: [Foreign Language] Let me start, I’d like to remind ...
Takeda is promoting U.S. chief Julie Kim to be its next CEO. AstraZeneca and Daiichi's Enhertu has won an FDA nod to expand into HER2-ultralow breast cancer. | Takeda is promoting U.S. chief Julie Kim ...
Takeda Pharmaceutical's strong earnings, dividends, and strategic moves make it an appealing investment despite US policy ...
After leading Japan’s largest drugmaker for 11 years, Takeda CEO Christophe Weber plans to step down in June of 2026. He will ...
Environmental experts have called for a ban on people and dogs at some coastal spots around Guernsey to protect wading bird ...
The Leader publishes death notices and funeral announcements from the families of loved ones who have passed away.
Hosted on MSN20h
Takeda announces appointment of Julie Kim as CEOI am excited to guide Takeda through the next phase, together with our exceptional and talented people, while staying true to ...
Analysts were unfazed by the news that Takeda will cease development of soticlestat after Phase III failures, while ...
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q3 2025Management ViewChristophe Weber, CEO, announced his retirement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback